arBtrage CAPITALIZING MARKETS — checking… Sign in Sign up
Calendar /

Universal Health Services, Inc.

UHS Health Care Hospital/Nursing Management
$169.65
▲ +0.0% Today
as of Sep 4, 16:55 ET
Last 30 days +2.06% Jul 28 → Sep 04
$162.06 $166.52 $170.99 $175.46 $179.92 Jul 28 Aug 05 Aug 12 Aug 20 Aug 27 Sep 04
Open
$167.20
High
$170.50
Low
$167.20
Volume
$381,960
Avg Vol
$803,118
Mkt Cap
$10.3B
P/E (TTM)
9.70
Beta
—
52w High
$246.33
52w Low
$140.08
Div Yield
—
Shares Out
—

Recent Press Releases & News last 60 days · 25 items

Sep 1 · 16:49 MT Newswires
JPMorgan Adjusts Universal Health Services Price Target to $200 From $205, Maintains Neutral Rating
Aug 26 · 15:30 Zacks
Why Is Universal Health Services (UHS) Up 5.7% Since Last Earnings Report?
Aug 26 · 03:10 Simply Wall St.
Universal Health Services (UHS) Stock Looks Undervalued As Returns Already Look Strong
▸ Show all 25 press releases & news Free account →

Overview

52-week range
$140
$246
28% of range
Avg surprise (last 2)
+10.7%
Avg reaction (last 1)
+0.7%
100% positive
Latest IV / EM
28%
EM ±4.4% · $170 · Sep 18

Earnings trends

EPS — actual vs estimate Actual Estimate
$2.28$3.21$4.13$5.05$5.98 Actual $2.28Actual $2.42Actual $2.40Actual $3.82Actual $4.26Actual $3.80Actual $4.84Est $4.36Actual $5.35Est $4.85Actual $5.86Actual $5.65Actual $5.98 MarJunSepMarJunSepMar/2025Jun/2025SepMarJun
Revenue vs Net Income Revenue Net income
$0$1.2B$2.4B$3.7B$4.9B Sep 24Mar 25Jun 25Sep 25Mar 26Jun 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Tue Jun 30, 2026Jun 2026 $5.98 — — — — financials
Tue Mar 31, 2026Mar 2026 $5.65 — — — — financials
Tue Sep 30, 2025Sep 2025 $5.86 — — — — financials
Mon Jul 28, 2025Jun/2025 $5.35 $4.85 +10.3% — — earnings
Mon Apr 28, 2025Mar/2025 $4.84 $4.36 +11.0% — +0.7% earnings
Mon Sep 30, 2024Sep 2024 $3.80 — — — — financials
Sun Jun 30, 2024Jun 2024 $4.26 — — — — financials
Sun Mar 31, 2024Mar 2024 $3.82 — — — — financials
Sat Sep 30, 2023Sep 2023 $2.40 — — — — financials
Fri Jun 30, 2023Jun 2023 $2.42 — — — — financials
Fri Mar 31, 2023Mar 2023 $2.28 — — — — financials

Financials

Income statement (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue$4.64B$4.50B—$4.50B$4.28B$4.10B—$3.96B
Cost of revenue————————
Gross profit————————
Operating income$517M$503M—$522M$500M$455M—$384M
Net income$358M$349M—$373M$353M$317M—$259M
EPS (diluted)$5.98$5.65—$5.86$5.43$4.80—$3.80

Balance sheet (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Cash & equivalents$139M$119M$138M$113M$138M$127M$126M$106M
Inventory————————
Total current assets$3.68B$3.50B$3.41B$3.26B$2.99B$3.08B$2.82B$2.80B
Total assets$15.94B$15.68B$15.53B$15.34B$14.99B$14.88B$14.47B$14.35B
Long-term debt$4.08B$3.95B$4.00B$3.95B$4.54B$4.61B$4.46B$4.62B
Total liabilities————————
Total equity$7.51B$7.53B$7.28B$7.17B$7.09B$6.87B$6.67B$6.68B

Implied volatility — last 90 days

28%50%73%95%118% Jun 07 — IV 46% · EM ±6.4%Jun 08 — IV 45% · EM ±5.9%Jun 09 — IV 44% · EM ±5.5%Jun 10 — IV 42% · EM ±4.9%Jun 11 — IV 41% · EM ±4.5%Jun 12 — IV 35% · EM ±3.6%Jun 15 — IV 50% · EM ±3.6%Jun 16 — IV 46% · EM ±2.7%Jun 17 — IV 118% · EM ±4.9%Jun 19 — IV 36% · EM ±7.9%Jun 22 — IV 36% · EM ±7.5%Jun 23 — IV 35% · EM ±7.2%Jun 24 — IV 33% · EM ±6.6%Jun 25 — IV 34% · EM ±6.6%Jun 26 — IV 34% · EM ±6.5%Jun 29 — IV 31% · EM ±5.5%Jun 30 — IV 36% · EM ±6.2%Jul 01 — IV 31% · EM ±5.1%Jul 02 — IV 33% · EM ±5.4%Jul 03 — IV 34% · EM ±5.4%Jul 06 — IV 34% · EM ±4.7%Jul 07 — IV 30% · EM ±4.0%Jul 08 — IV 38% · EM ±4.7%Jul 09 — IV 36% · EM ±4.3%Jul 10 — IV 40% · EM ±4.4%Jul 13 — IV 50% · EM ±4.2%Jul 14 — IV 50% · EM ±3.6%Jul 15 — IV 59% · EM ±3.5%Jul 16 — IV 66% · EM ±2.8%Jul 20 — IV 47% · EM ±11.2%Jul 21 — IV 48% · EM ±11.2%Jul 22 — IV 47% · EM ±10.6%Jul 23 — IV 47% · EM ±10.6%Jul 24 — IV 48% · EM ±10.6%Jul 27 — IV 70% · EM ±14.7%Jul 28 — IV 39% · EM ±7.9%Jul 29 — IV 32% · EM ±6.5%Jul 30 — IV 31% · EM ±6.1%Jul 31 — IV 44% · EM ±8.4%Aug 03 — IV 34% · EM ±6.0%Aug 04 — IV 34% · EM ±5.8%Aug 05 — IV 33% · EM ±5.5%Aug 06 — IV 31% · EM ±5.0%Aug 07 — IV 32% · EM ±5.0%Aug 10 — IV 31% · EM ±4.2%Aug 11 — IV 34% · EM ±4.4%Aug 12 — IV 34% · EM ±4.3%Aug 13 — IV 31% · EM ±3.7%Aug 14 — IV 28% · EM ±3.1%Aug 17 — IV 34% · EM ±2.8%Aug 18 — IV 43% · EM ±3.1%Aug 19 — IV 45% · EM ±2.6%Aug 20 — IV 42% · EM ±1.8%Aug 24 — IV 32% · EM ±6.7%Aug 25 — IV 30% · EM ±6.2%Aug 26 — IV 31% · EM ±6.1%Aug 27 — IV 31% · EM ±6.1%Aug 28 — IV 29% · EM ±5.6%Aug 31 — IV 30% · EM ±5.3%Sep 01 — IV 30% · EM ±5.2%Sep 02 — IV 35% · EM ±5.8%Sep 03 — IV 29% · EM ±4.7%Sep 04 — IV 28% · EM ±4.4%

Sector peers

LLY
Eli Lilly and Company
$1.1T $1,148.00-0.1%
JNJ
Johnson & Johnson
$671.0B $275.71+0.2%
ABBV
AbbVie Inc.
$430.9B $256.50+0.1%
MRK
Merck & Company, Inc.
$317.1B $150.33+0.0%
PM
Philip Morris International Inc
$299.3B $182.53+0.0%
NVS
Novartis AG
$297.9B $155.11-3.0%
View on Nasdaq ↗
🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.
Sign up free → Sign in